Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triacetoxyperiodinane | HCID 159087 | — |
| Reactant | 4-{hydroxy-[5-triisopropylsilanyl-2-(3,4,5-trimethoxy-phenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]-methyl}-4-methyl-piperidine-1-carboxylic acid tert-butyl ester | HCID 59540603 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | Ammonium Hydroxide | HCID 14923 | — |
| Product | 4-methyl-4-[5-triisopropylsilanyl-2-(3,4,5-trimethoxy-phenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-piperidine-1-carboxylic acid tert-butyl ester | HCID 59540581 | — |
| Product | 4-methyl-4-[2-(3,4,5-trimethoxy-phenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-piperidine-1-carboxylic acid tert-butyl ester | HCID 59540868 | — |
Reaction Steps
To a solution of 4-{hydroxy-[5-triisopropylsilanyl-2-(3,4,5-trimethoxy-phenyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]-methyl}-4-methyl-piperidine-1-carboxylic acid tert-butyl ester from above (950 mg, ˜1.4 mmol) in CH2Cl2 (5 mL) was added Dess-Martin periodinane (900 mg, 2.1 mmol) portionwise. The resultant orange suspension was allowed to stir for 1 h and partitioned between 1:1 saturated Na2S2O3:saturated NaHCO3 and CH2Cl2. The aqueous phase was extracted with CH2Cl2 and the combined organic phases were dried over Na2SO4 and concentrated to give a tan solid. The crude product was purified by flash chromatography using 25 g of silica gel and 0-30% of 9.5:0.5 MeOH:conc NH4OH in CH2Cl2 as eluant to afford 150 mg of impure 4-methyl-4-[2-(3,4,5-trimethoxy-phenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-piperidine-1-carboxylic acid tert-butyl ester, M+Na 533, and 0.24 g of impure 4-methyl-4-[5-triisopropylsilanyl-2-(3,4,5-trimethoxy-phenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-piperidine-1-carboxylic acid tert-butyl ester, M+Na 689.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08008298B2 |
|---|
| Source dataset | uspto-grants-2011_08 |
|---|
| ORD ID | ord-2693fa902f554476aed363d3a008d3ae |
|---|
| Source note | uspto-grants-2011_08 |
|---|